Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Citigroup Upgrades Core Laboratories to Neutral

Citigroup Upgrades Core Laboratories to Neutral

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral.

byBenzinga Newsdesk

October 7, 2022

1 minute read

Citigroup analyst Scott Gruber upgrades Core Laboratories (NYSE:CLB) from Sell to Neutral.

News

More Chinese Cities Eased Covid Restrictions Over the Weekend

By Charles Gross

December 4, 8:21 PM

https://www.bloomberg.com/news/articles/2022-12-04/more-china-cities-ease-curbs-in-expansion-of-covid-policy-shift

FXI

Analyst Ratings

7 Analysts Have This to Say About Imax

By Benzinga Insights

April 10, 4:00 PM

Imax (NYSE:IMAX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

IMAX

Wells Fargo Maintains Equal-Weight on Portland Gen Electric, Lowers Price Target to $48

By Benzinga Newsdesk

October 19, 9:47 AM

Wells Fargo analyst Sarah Akers maintains Portland Gen Electric (NYSE:POR) with a Equal-Weight and lowers the price target from $54 to $48.

POR

Analyst Ratings

Baird Maintains Neutral Rating for Albany Intl: Here’s What You Need To Know

By Benzinga Insights

October 26, 12:33 PM

Baird has decided to maintain its Neutral rating of Albany Intl (NYSE:AIN) and raise its price target from $95.00 to $101.00. Shares of Albany Intl are trading up 3.04% over the last 24 hours, at $90.57 per share. A move to $101.00 would account for a 11.52% increase from the current share price.

AIN

Citigroup Upgrades Core Laboratories to Neutral

Related Posts

More Chinese Cities Eased Covid Restrictions Over the Weekend

7 Analysts Have This to Say About Imax

Wells Fargo Maintains Equal-Weight on Portland Gen Electric, Lowers Price Target to $48

Baird Maintains Neutral Rating for Albany Intl: Here’s What You Need To Know